Tag:
neuroscience research
Latest Headlines
Latest Headlines
Final PhIII results wipe out AstraZeneca, Targacept depression drug
AstraZeneca ( $AZN ) and Targacept ( $TRGT ) made it official today that their partnered depression drug--TC-5214--proved a complete bust in Phase III.
Scientists warn on "dead space" as pharma giants shun neuropsych
European experts are sounding an alarm about the recent pullout of GlaxoSmithKline and AstraZeneca from the brain disorder arena. David Nutt, a professor Imperial College London, and Oxford's Guy
